- 30 June 2009
Utrophin injection may offer a new treatment strategy for Duchenne Research in the US has discovered that direct replacement of dystrophin with a closely related protein called utrophin could help to treat Duchenne muscular dystrophy. - 24 June 2009
Researchers uncover new cause for limb girdle 2B Potential new treatments on the horizon as UK researchers funded by the Muscular Dystrophy Campaign identify a biological process that causes muscle diseases known as dysferlinopathies, which includes limb girdle type 2B. - 27 May 2009
Vital new insights into muscle stem cells Research funded by the Muscular Dystrophy Campaign at King’s College London has shed new light on the biology of muscle stem cells which brings us a step closer to using them as a therapy for muscle disease. - 20 May 2009
Limb girdle muscular dystrophy clinical trial shows promise Researchers in the US have published encouraging results in the search for a treatment for limb girdle muscular dystrophy type 2D (LGMD2D). - 11 May 2009
Exclusive visit to Dame Professor Kay Davies' lab We visited Professor Dame Kay Davies’ laboratory for an update on their ground breaking research which aims to find a treatment for Duchenne muscular dystrophy. - 4 May 2009
Potential new drug for myasthenia gravis Recent research in the US has shown that the symptoms of myasthenia gravis in rats can be dramatically reduced by a protein from tick saliva. - 21 April 2009
Research improves exon skipping for Duchenne Muscular Dystrophy Campaign funded research in Oxford has improved exon skipping technology for Duchenne muscular dystrophy. The modifications, tested in a mouse model, resulted in improved efficiency of dystrophin production, including in the heart - 7 April 2009
Dystrophin breakthrough may improve gene therapy for Duchenne muscular dystrophy New information about the dystrophin protein has allowed US researchers to design new gene therapy agents which were more effective in a mouse model of Duchenne muscular dystrophy. - 30 March 2009
Mouse model developed to study congenital muscular dystrophy Scientists at Imperial College London have created a mouse model of a severe form of congenital muscular dystrophy called muscle-eye-brain disease. - 20 March 2009
Potential heart drug for Emery-Dreifuss muscular dystrophy A drug known as PD98059 has been shown to be an effective treatment in mice for the heart complications of Emery-Dreifuss muscular dystrophy.
